| Alterations of the human gut Methanobrevibacter smithii as a biomarker for inflammatory bowel diseases SB Ghavami, E Rostami, AA Sephay, S Shahrokh, H Balaii, HA Aghdaei, ... Microbial pathogenesis 117, 285-289, 2018 | 98 | 2018 |
| Toxicity and unusual biological behavior of nanosilver on gram positive and negative bacteria assayed by microtiter-plate S Shahrokh, G Emtiazi Eur J Biol Sci 1 (3), 28-31, 2009 | 75 | 2009 |
| Evaluation of tumor necrosis factor (TNF)-α mRNA expression level and the rs1799964 polymorphism of the TNF-α gene in peripheral mononuclear cells of patients with inflammatory … M Nourian, V Chaleshi, L Pishkar, P Azimzadeh, S Baradaran Ghavami, ... Biomedical reports 6 (6), 698-702, 2017 | 73 | 2017 |
| The role of serum calprotectin as a novel biomarker in inflammatory bowel diseases: a review study TA Kopi, S Shahrokh, S Mirzaei, HA Aghdaei, AA Kadijani Gastroenterology and hepatology from bed to bench 12 (3), 183, 2019 | 66 | 2019 |
| Prevalence of the pathobiont adherent‐invasive Escherichia coli and inflammatory bowel disease: a systematic review and meta‐analysis B Nadalian, A Yadegar, H Houri, M Olfatifar, S Shahrokh, ... Journal of gastroenterology and hepatology 36 (4), 852-863, 2021 | 54 | 2021 |
| Diagnostic potency of EUS-guided FNA for the evaluation of pancreatic mass lesions AHM Alizadeh, S Shahrokh, M Hadizadeh, M Padashi, MR Zali Endoscopic ultrasound 5 (1), 30-34, 2016 | 47 | 2016 |
| The emerging epidemic of inflammatory bowel disease in Asia and Iran by 2035: A modeling study M Olfatifar, MR Zali, MA Pourhoseingholi, H Balaii, SB Ghavami, ... BMC gastroenterology 21 (1), 204, 2021 | 44 | 2021 |
| Effects of flaxseed and flaxseed oil supplement on serum levels of inflammatory markers, metabolic parameters and severity of disease in patients with ulcerative colitis N Morshedzadeh, S Shahrokh, HA Aghdaei, MA Pourhoseingholi, ... Complementary therapies in medicine 46, 36-43, 2019 | 44 | 2019 |
| The PI3K/Akt/mTOR axis in colorectal cancer: Oncogenic alterations, non‐coding RNAs, therapeutic opportunities, and the emerging role of nanoparticles MJ Sanaei, A Baghery Saghchy Khorasani, A Pourbagheri‐Sigaroodi, ... Journal of Cellular Physiology 237 (3), 1720-1752, 2022 | 36 | 2022 |
| Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study M Azimirad, M Krutova, A Yadegar, S Shahrokh, M Olfatifar, HA Aghdaei, ... Emerging microbes & infections 9 (1), 1432-1443, 2020 | 35 | 2020 |
| Altered fecal bacterial composition correlates with disease activity in inflammatory bowel disease and the extent of IL8 induction F Heidarian, M Alebouyeh, S Shahrokh, H Balaii, MR Zali Current research in translational medicine 67 (2), 41-50, 2019 | 35 | 2019 |
| Cross-talk between immune system and microbiota in COVID-19 S Baradaran Ghavami, M Pourhamzeh, M Farmani, SKA Raftar, ... Expert review of gastroenterology & hepatology 15 (11), 1281-1294, 2021 | 34 | 2021 |
| Gut mycobiome: The probable determinative role of fungi in IBD patients A Beheshti‐Maal, S Shahrokh, S Ansari, ES Mirsamadi, A Yadegar, ... Mycoses 64 (5), 468-476, 2021 | 34 | 2021 |
| Immunomodulation and generation of tolerogenic dendritic cells by probiotic bacteria in patients with inflammatory bowel disease SB Ghavami, A Yadegar, HA Aghdaei, D Sorrentino, M Farmani, AS Mir, ... International journal of molecular sciences 21 (17), 6266, 2020 | 34 | 2020 |
| An increased Bax/Bcl-2 ratio in circulating inflammatory cells predicts primary response to infliximab in inflammatory bowel disease patients HA Aghdaei, AA Kadijani, D Sorrentino, A Mirzaei, S Shahrokh, H Balaii, ... United European gastroenterology journal 6 (7), 1074-1081, 2018 | 32 | 2018 |
| Association between adipokines levels with inflammatory bowel disease (IBD): systematic reviews N Morshedzadeh, M Rahimlou, H Asadzadeh Aghdaei, S Shahrokh, ... Digestive diseases and sciences 62, 3280-3286, 2017 | 30 | 2017 |
| Transmembrane TNF-α density, but not soluble TNF-α level, is associated with primary response to infliximab in inflammatory bowel disease AA Kadijani, HA Aghdaei, D Sorrentino, A Mirzaei, S Shahrokh, H Balaii, ... Clinical and translational gastroenterology 8 (9), e117, 2017 | 30 | 2017 |
| How does COVID-19 pandemic impact on incidence of Clostridioides difficile infection and exacerbation of its gastrointestinal symptoms? M Azimirad, M Noori, H Raeisi, A Yadegar, S Shahrokh, ... Frontiers in medicine 8, 775063, 2021 | 28 | 2021 |
| Signature of gut microbiome by conventional and advanced analysis techniques: advantages and disadvantages S Rezasoltani, DA Bashirzadeh, EN Mojarad, HA Aghdaei, M Norouzinia, ... Middle East journal of digestive diseases 12 (1), 5, 2020 | 27 | 2020 |
| Contribution of NOTCH signaling pathway along with TNF-α in the intestinal inflammation of ulcerative colitis M Ghorbaninejad, R Heydari, P Mohammadi, S Shahrokh, M Haghazali, ... Gastroenterology and hepatology from bed to bench 12 (Suppl1), S80, 2019 | 26 | 2019 |
